Guillain-Barré syndrome after COVID-19 vaccination

We report a case of Guillain-Barré syndrome (GBS) occurring soon after the first dose of Vaxzevria (previously known as COVID-19 vaccine AstraZeneca). Thus far, there has been no evidence of an increased risk of GBS resulting from either COVID-19 infection nor from COVID-19 vaccines; however, indivi...

Descripción completa

Detalles Bibliográficos
Autores principales: McKean, Norma, Chircop, Charmaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327820/
https://www.ncbi.nlm.nih.gov/pubmed/34330729
http://dx.doi.org/10.1136/bcr-2021-244125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327820/
https://www.ncbi.nlm.nih.gov/pubmed/34330729
http://dx.doi.org/10.1136/bcr-2021-244125

Ejemplares similares